Efficacy of Teprotumumab Therapy in Patients With a Low Clinical Activity Scale Score and/or Long-Duration Thyroid Eye Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Current Opinion in Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of teprotumumab therapy in patients with long-duration thyroid eye disease
Curr Opin Ophthalmol 2023 Nov 01;34(6)487-492, PS Subramanian, RI Cho, A KahanaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.